Biotech financing
25WmEet
25WmEet
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Biotech</strong> <strong>financing</strong>: United States<br />
United States<br />
US biotechnology <strong>financing</strong>s by year<br />
Debt Follow-on and other IPOs<br />
Venture<br />
70<br />
60<br />
50<br />
US$b<br />
40<br />
30<br />
20<br />
10<br />
0<br />
Source: EY, Capital IQ and VentureSource.<br />
In the US, 2015 featured strong <strong>financing</strong> performance across<br />
every category. With a total of US$61.1 billion raised (up 32%<br />
from 2014’s then-record US$46.4 billion), the year featured the<br />
highest-ever venture capital, debt and follow-on <strong>financing</strong> totals.<br />
Fourth quarter <strong>financing</strong> slowed significantly, with only US$4.6<br />
billion of the year’s total coming during the last three months<br />
of 2015.<br />
12 Beyond borders 2016 — <strong>Biotech</strong> <strong>financing</strong>
Change language